Trademark: 98023632
Word
IMMUNOVEDA
Status Date
Tuesday, June 18, 2024
Registration Number
7420266
Registration Date
Tuesday, June 18, 2024
Filing Date
Thursday, June 1, 2023
Published for Opposition
Tuesday, April 2, 2024
42 Research and development of pharmaceuticals for the treatment of age-related diseases and cancer; Medical research services in the field of cancer; Medical and scientific research in the field of cancer treatment and diagnosis; Providing laboratory research services in the field of gene expression, namely, cancer biology
The mark consists of the word "IMMUNOVEDA" in purple, above the letter "I" is a purple dot; starting from this first dot is series of gradient purple to blue dots with each dot getting smaller in size and lighter in contrast to the first dot, and the space between the dots increases as the dots sweep upward in a curve toward the top of the mark, creating a band of dots, reaching an apex whereupon they descend in a curve toward the letter "A", upon reaching the letter "A" in one single dot whereupon they end. The color white represents background and transparent areas and is not part of the mark.
The color(s) blue and purple is/are claimed as a feature of the mark.
Jun 5, 2023
New Application Entered
Jul 7, 2023
Notice Of Design Search Code E-Mailed
Sep 15, 2023
Attorney/Dom.Rep.Revoked And/Or Appointed
Sep 15, 2023
Teas Withdrawal Of Attorney Received-Firm Retains
Sep 15, 2023
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Feb 23, 2024
Assigned To Examiner
Feb 23, 2024
Approved For Pub - Principal Register
Jul 6, 2023
New Application Office Supplied Data Entered
Sep 15, 2023
Teas Change Of Correspondence Received
Mar 13, 2024
Notification Of Notice Of Publication E-Mailed
Apr 2, 2024
Published For Opposition
Apr 2, 2024
Official Gazette Publication Confirmation E-Mailed
Jun 18, 2024
Registered-Principal Register
Jun 18, 2024
Notice Of Registration Confirmation Emailed
Trademark Alertz updated from USPTO on 2030-01-24
